SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Paimon SpaceX SPV Token (SPCX) offers investors exclusive access to SpaceX's growth potential through a British Virgin Islands Special Purpose Vehicle structure. Each token represents fractional ownership in the underlying SPV that invests in venture capital funds with SpaceX exposure. SPCX provides a unique opportunity to participate in the space industry's leading innovator. The token structure enables global qualified investors to access this premium late-stage venture equity that would typically be unavailable to most. SPCX is deployed on BNB Chain with plans for multi-chain expansion.

Paimon SpaceX SPV Token

Market speculation is intensifying around a potential SpaceX IPO under the ticker SPCX, with community members actively discussing valuation expectations and the potential for spillover momentum into aerospace industry proxies. Investors are heavily focused on the logistical details of the rumored listing timeline and the broader implications for liquidity across the sector.

Kura Sushi USA, Inc. engages in the operation of technology enabled Japanese restaurants. It offers a distinctive dining experience by serving authentic Japanese cuisine through engaging revolving sushi service models. The company was founded by Hajime Uba in 2008 and is headquartered in Irvine, CA.

Kura Sushi USA Inc - Ordinary Shares - Class A

Kura Sushi USA is trending as investors debate the impact of potential tariffs and recent volatility, while the community remains divided over its long-term growth versus valuation concerns. Discussions are heavily focused on the stock's historical tendency for sharp swings and the divergence between its rapid unit expansion and recent price performance.

Tema ETF Trust - Tema Space Innovators ETF

The $NASA ETF is trending as investors rush to gain exposure to the highly anticipated SpaceX IPO through the fund's 10% stake in the private company, alongside other space infrastructure holdings. Community sentiment is overwhelmingly bullish, with retail investors comparing its potential trajectory to other high-volatility space plays and actively discussing the fund's asset growth as a proxy for the broader commercial space economy.

DocuSign, Inc. engages in the provision of cloud-based electronic signature solutions, which helps companies and individuals securely collect information, automate data workflows, and sign anything. The firm automates manual and paper-based processes allowing users to manage all aspects of documented business transactions including identity management, authentication, digital signature, forms and data collection, collaboration, workflow automation, and storage. Its products include eSignature, CLM, Gen for Salesforce, Document Generation, Standards-Based Signatures, Notary and Web Forms. The company was founded by Thomas H. Gonser and Court Lorenzini in 2003 and is headquartered in San Francisco, CA.

DocuSign Inc

DocuSign is trending as investors weigh strong earnings and share repurchases against cautious forward guidance, sparking debate over whether the firm's AI-driven Intelligent Agreement Management (IAM) platform can maintain a competitive moat. Community sentiment remains sharply divided between bulls betting on a valuation recovery fueled by solid fundamentals and bears concerned that AI disruption will commoditize the company's core signature services.

NeoGenomics, Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. The company was founded by Michael T. Dent on October 29, 1998 and is headquartered in Fort Myers, FL.

Neogenomics Inc.

NeoGenomics is trending as investors respond to accelerating revenue growth, particularly in its high-margin NGS segment, and optimism surrounding the strategic integration of its cancer testing into the Epic Aura hospital network. The community is actively discussing the companys pivot toward becoming a precision oncology data powerhouse, with many bulls anticipating that strong fundamental execution and clinical footprint will drive a sustained re-rating.

Pulse Biosciences, Inc. operates as an immuno-oncology company developing a proprietary oncolytic electroceutical therapy based on its Nano Pulse Stimulation (NPS) technology. It manufactures surgical and medical instruments using a novel and proprietary platform technology called Nano-Pulse Electro-Signaling. The NPES provides local tumor control and initiates an adaptive immune response with a vaccine-like effect by inducing immunogenic apoptosis of the cells. The company was founded on May 19, 2014 and is headquartered in Miami, FL.

Pulse Biosciences Inc

Pulse Biosciences is trending due to heightened investor enthusiasm surrounding its proprietary Nanosecond Pulsed Field Ablation technology, which is being positioned as a potential breakthrough in cardiac and soft tissue treatment. The community is actively discussing the stock's clinical study milestones, aggressive insider buying by company leadership, and potential for a future buyout or strategic partnership.

Stubhub Holdings, Inc. provides online ticket selling services. It also provides services for buyers and sellers of tickets for sports, concerts, theater, and other live entertainment events. The company was founded by Eric H. Baker in 2000 and is headquartered in New York, NY.

Stubhub Holdings Inc. - Ordinary Shares - Class A

StubHub

StubHub is trending as investors debate the impact of potential regulatory crackdowns and shifting ticket market dynamics, with significant community discourse focused on whether the stock's recent volatility presents a deep-value opportunity or a long-term risk. Sentiment remains polarized between those monitoring institutional accumulation and those cautious of the company's competitive moats and legal exposure.

Bankr is an advanced AI agent focused on simplifying the process of buying and selling digital assets. Bankr was the first AI agent on Farcaster to help you quickly buy all your favorites coins directly in the social. BankrCoin is the official coin of the agent and was deployed by Bankr itself directly in the Farcaster social feed. Fees from swaps go to support BankrCoin. Bankr is available on Farcaster and will soon be launching a private terminal, token recs, and limit orders on Base.

BankrCoin

BankrCoin ($BNKR) is trending as the community highlights its role as infrastructure for autonomous on-chain AI agents within the Base ecosystem. Investors are actively discussing the token's accumulation phase, the potential for long-term utility-driven growth, and the ongoing development of its bot capabilities that facilitate on-chain DeFi transactions.

The World Collective Oil Reserve (WCOR) is a public-information program built on the Solana blockchain that mirrors the structure and reporting discipline of national strategic petroleum reserves. It applies established supply-security concepts — including import cover, shock response, emergency release protocols, and transparent stock reporting — to an open, permissionless environment. Data published through the program is drawn from public sources, with approximations clearly identified, and reserve records are maintained on-chain to support auditability, traceability, and independent verification. WCOR is presented as an informational and reference framework rather than a financial product, translating the reporting conventions of traditional strategic inventories into a blockchain-native format that any participant can inspect or cite.

World Collective Oil Reserve

WCOR is experiencing a surge in social media attention as investors speculate on its growth potential, though community members remain divided between excitement over recent gains and concerns regarding its status as a high-risk meme coin. Discussion is heavily focused on technical challenges and confusion surrounding the token's availability across different blockchain networks and trading platforms.

Elbit Systems Ltd. engages in the defense and homeland security sector. It develops and supplies airborne, land and naval systems and products for defense, homeland security, and commercial applications. The firm also provides training and support services. The company was founded in 1996 and is headquartered in Haifa, Israel.

Elbit Systems Ltd.

Elbit Systems is capturing significant market attention as investors weigh its robust global order backlog against ongoing geopolitical demand for its specialized defense and surveillance technologies. While some market participants debate the stock's valuation, community discussion is heavily focused on potential new partnerships and the company's critical role in the expanding defense technology sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

electroCore Q1 Earnings Call Highlights

electroCore (NASDAQ:ECOR) executives highlighted record quarterly revenue, expanding margins, and continued progress toward profitability during the company's first-quarter 2026 earnings call, while also discussing a leadership transition and commercial priorities across federal and consumer channel...

electroCore, Inc. (ECOR) Reports Q1 Loss, Beats Revenue Estimates

electroCore (ECOR) delivered earnings and revenue surprises of -0.86% and +7.14%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Insider Selling: electroCore (NASDAQ:ECOR) Director Sells 16,072 Shares of Stock

electroCore, Inc. (NASDAQ:ECOR - Get Free Report) Director Daniel Goldberger sold 16,072 shares of electroCore stock in a transaction dated Friday, April 10th. The stock was sold at an average price of $6.02, for a total value of $96,753.44. Following the sale, the director directly owned 291,471...

electroCore (NASDAQ:ECOR) Director Daniel Goldberger Sells 16,072 Shares

electroCore, Inc. (NASDAQ:ECOR - Get Free Report) Director Daniel Goldberger sold 16,072 shares of the firm's stock in a transaction that occurred on Friday, April 10th. The stock was sold at an average price of $6.02, for a total transaction of $96,753.44. Following the sale, the director owned...

electroCore (ECOR) Moves 7.1% Higher: Will This Strength Last?

electroCore (ECOR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Relay Therapeutics (RLAY) Surges 16.4%: Is This an Indication of Further Gains?

Relay Therapeutics (RLAY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

Analysts Offer Predictions for electroCore FY2030 Earnings

electroCore, Inc. (NASDAQ:ECOR - Free Report) - Equities researchers at HC Wainwright lifted their FY2030 earnings per share estimates for shares of electroCore in a research note issued to investors on Friday, March 20th. HC Wainwright analyst S. Ramakanth now anticipates that the company will post...

electroCore (NASDAQ:ECOR) Releases Quarterly Earnings Results, Beats Estimates By $0.01 EPS

electroCore (NASDAQ:ECOR - Get Free Report) issued its earnings results on Thursday. The company reported ($0.34) earnings per share for the quarter, topping the consensus estimate of ($0.35) by $0.01. The firm had revenue of $9.24 million for the quarter, compared to analyst estimates of $9.09...

electroCore (ECOR) Q4 2025 Earnings Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

electroCore Q4 Earnings Call Highlights

electroCore (NASDAQ:ECOR) executives highlighted record fourth-quarter revenue growth, expanding adoption within the U.S. Department of Veterans Affairs (VA) system, and accelerating sales of its Truvaga wellness product during the company's fourth-quarter and full-year 2025 earnings call. Managemen...

electroCore, Inc. engages in the provision of non-invasive vagus nerve stimulation (nVNS) therapy. It develops a platform bioelectronic medical therapy that modulates neurotransmitters and immune function through its effects on both the peripheral and central nervous systems. The company was founded by Joseph P. Errico, Steven M. Mendez, Peter S. Staats and Thomas J. Errico in September 2005 and is headquartered in Rockaway, NJ.

Current Price	$6.27
Prev Close	$6.43
Open	$6.27
Dividend Yield	0.00%
50-Day Moving Average	$6.42
Beta	1.02
Avg. Volume	68,061.63
PE Ratio	-3.46

52-Week High	$8.64
52-Week Low	$4.16
Market Capitalization	$52.01M
EPS (Annual)	-$1.65
Price to Book	-8.96
Revenue Per Employee	$385,927.71

ECOR
ElectroCore Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ECOR News

ECORElectroCore Inc